Tandem Diabetes Care, Inc. (FRA:TD5A)

Market Cap	1.21B +21.1%
Revenue (ttm)	864.25M +7.9%
Net Income	-174.35M
EPS	-2.59
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	31
Open	17.60
Previous Close	17.60
Day's Range	17.60 - 17.60
52-Week Range	8.79 - 23.09
Beta	n/a
RSI	48.19
Earnings Date	May 7, 2026

About Tandem Diabetes Care

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It’s flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user’s body. In addition, it offers Tandem Device Updater used to update the pump software from a pe...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2006
• Employees: 2,500
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: TD5A

Financial Performance

In 2025, Tandem Diabetes Care's revenue was $1.01 billion, an increase of 7.93% compared to the previous year's $940.20 million. Losses were -$204.71 million, 113.2% more than in 2024.

Financial numbers in USD